David Roman
Stock Analyst at Goldman Sachs
(3.65)
# 2,134
Out of 5,020 analysts
244
Total ratings
52.5%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $23.64 | -11.17% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $18.87 | +0.69% | 7 | Jul 15, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $19 → $21 | $16.94 | +23.97% | 4 | Jul 14, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $57 | $43.23 | +31.85% | 11 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $9.03 | +243.30% | 2 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $21 → $16 | $16.50 | -3.03% | 7 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $95 → $98 | $85.19 | +15.04% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $401.24 | +39.07% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $25 | $20.41 | +22.49% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $84 → $83 | $86.44 | -3.98% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $24 | $19.60 | +22.45% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $113 | $96.69 | +16.87% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $89 → $88 | $89.37 | -1.53% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $73 → $61 | $57.41 | +6.25% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $205 | $130.79 | +56.74% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $5.67 | +41.09% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $163.17 | -6.23% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $28.50 | -15.79% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $86.23 | -7.22% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $18.75 | +6.67% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $72 | $74.70 | -3.61% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $50 | $34.94 | +43.10% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $13.76 | +16.28% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54 → $66 | $87.77 | -24.80% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $357 → $361 | $272.96 | +32.25% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $63.98 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $147 | $111.05 | +32.37% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $178.07 | -6.22% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $27.12 | -37.30% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $93 → $88 | $88.06 | -0.07% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $74.41 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $104.37 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $103 | $94.34 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $15 | $9.30 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $23.64
Upside: -11.17%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $18.87
Upside: +0.69%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $16.94
Upside: +23.97%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $43.23
Upside: +31.85%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $9.03
Upside: +243.30%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $16.50
Upside: -3.03%
Edwards Lifesciences
Jun 15, 2026
Reiterated: Buy
Price Target: $95 → $98
Current: $85.19
Upside: +15.04%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $401.24
Upside: +39.07%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $20.41
Upside: +22.49%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $86.44
Upside: -3.98%
Jun 3, 2026
Reiterated: Buy
Price Target: $14 → $24
Current: $19.60
Upside: +22.45%
May 31, 2026
Reiterated: Buy
Price Target: $121 → $113
Current: $96.69
Upside: +16.87%
May 29, 2026
Reiterated: Sell
Price Target: $89 → $88
Current: $89.37
Upside: -1.53%
May 27, 2026
Reiterated: Sell
Price Target: $73 → $61
Current: $57.41
Upside: +6.25%
May 27, 2026
Reiterated: Buy
Price Target: $237 → $205
Current: $130.79
Upside: +56.74%
May 27, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $5.67
Upside: +41.09%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $163.17
Upside: -6.23%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $28.50
Upside: -15.79%
May 15, 2026
Reiterated: Buy
Price Target: $80
Current: $86.23
Upside: -7.22%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $18.75
Upside: +6.67%
May 6, 2026
Reiterated: Hold
Price Target: $73 → $72
Current: $74.70
Upside: -3.61%
May 6, 2026
Reiterated: Buy
Price Target: $54 → $50
Current: $34.94
Upside: +43.10%
May 5, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $13.76
Upside: +16.28%
May 5, 2026
Reiterated: Sell
Price Target: $54 → $66
Current: $87.77
Upside: -24.80%
May 1, 2026
Reiterated: Hold
Price Target: $357 → $361
Current: $272.96
Upside: +32.25%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $63.98
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: $147
Current: $111.05
Upside: +32.37%
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $178.07
Upside: -6.22%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $27.12
Upside: -37.30%
Feb 10, 2026
Reiterated: Sell
Price Target: $93 → $88
Current: $88.06
Upside: -0.07%
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $74.41
Upside: n/a
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $104.37
Upside: n/a
Nov 15, 2013
Reiterated: Sell
Price Target: $103
Current: $94.34
Upside: n/a
Aug 30, 2012
Reiterated: Hold
Price Target: $44 → $15
Current: $9.30
Upside: n/a